Q4 FY2025 · Presentation
Preliminary Phase 1_2 Clinical Data Readout for DM1 and FSHD Programs · 37 pages
Read Sarepta Therapeutics, Inc.'s results firsthand
Preview the first 2 pages of this presentation
Create a free account to start reading
Full documents are included with Professional